Show
Sort by
-
Luspatercept in patients with lower-risk myelodysplastic syndromes
-
Surveillance of myelodysplastic syndrome via migration analyses of blood neutrophils : a potential prognostic tool
-
The Medalist trial : results of a phase 3, randomized, double-blind, placebo-controlled study of luspatercept to treat anemia in patients with very low-, low-, or intermediate-risk myelodysplastic syndromes (MDS) with ring sideroblasts (RS) who require red blood cell (RBC) transfusions
-
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia